Alexandria Real Estate Equities (ARE) has been facing some market challenges as reflected in lowered guidance and major write-downs, leading to substantial drops in the company's stock price. ARE's Q3 and YTD Q3 net loss per share were reported to be $1.38 and $2.09 respectively, causing shares to plummet. The company's stock has further been hit by recent downgrades from Citigroup and Royal Bank of Canada. Despite the turbulent times, some investors such as
American Assets Capital Advisers and
Bank of Montreal have increased their stake in the company. The company's Q3 earnings lagged behind estimates, triggering further downslide in share prices. The sale of the Watertown Mall and a focus on dividends have further made investors wary. However, the outlook is not entirely grim.
Washburn Capital Management,
Versor Investments, and a few others have made new investments in ARE. The firm is also forming strategic partnerships, such as with
Lilly Gateway Labs, to foster development of life-changing medicines. Going forward, a bounce-back of ARE in the stock market remains to be seen.
Alexandria Real Estate Equities ARE News Analytics from Fri, 26 Sep 2025 07:00:00 GMT to Sun, 09 Nov 2025 01:08:16 GMT -
Rating -6
- Innovation -4
- Information 2
- Rumor -7
